Join the Sympazan group to help and get support from people like you.
Sympazan News
FDA Medwatch Alert: FDA Warns of Rare But Serious Drug Reaction to the Antiseizure Medicines Levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and Clobazam (Onfi, Sympazan)
November 28, 2023 – FDA Warns of Rare But Serious Drug Reaction to the Antiseizure Medicines Levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and Clobazam (Onfi, Sympazan) What safety...
Study Looks at Links Between Anxiety Disorders, Benzodiazepines, Dementia
MONDAY, Aug. 14, 2023 – Benzodiazepines and anxiety disorders are associated with dementia risk, but for patients with anxiety disorders, no additional risk is seen with benzodiazepine use,...
FDA Medwatch Alert: Drug Safety Communication: Benzodiazepine Drug Class - Boxed Warning Updated to Improve Safe Use
ISSUE: The FDA is requiring the Boxed Warning, FDA’s most prominent warning, be updated by adding other information to the prescribing information for all benzodiazepine medicines. This information w...
FDA Approves Sympazan (clobazam) Oral Film for Adjunctive Treatment of Seizures Associated with Lennox-Gastaut Syndrome
WARREN, N.J., Nov. 2, 2018 /PRNewswire/ – Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) approved...
Ask a question
To post your own question to this support group, sign in or create an account.